Log in to save to my catalogue

Selective Killing of Cancer Cells by β-Lapachone: Direct Checkpoint Activation as a Strategy against...

Selective Killing of Cancer Cells by β-Lapachone: Direct Checkpoint Activation as a Strategy against...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_12598645

Selective Killing of Cancer Cells by β-Lapachone: Direct Checkpoint Activation as a Strategy against Cancer

About this item

Full title

Selective Killing of Cancer Cells by β-Lapachone: Direct Checkpoint Activation as a Strategy against Cancer

Publisher

United States: National Academy of Sciences

Journal title

Proceedings of the National Academy of Sciences - PNAS, 2003-03, Vol.100 (5), p.2674-2678

Language

English

Formats

Publication information

Publisher

United States: National Academy of Sciences

More information

Scope and Contents

Contents

Most chemotherapeutic drugs kill cancer cells by indirectly activating checkpoint-mediated apoptosis after creating nonselective damage to DNA or microtubules, which accounts for their toxicity toward normal cells. We seek to target cancer cells by directly activating checkpoint regulators without creating such damage. Here, we show that β-lapachon...

Alternative Titles

Full title

Selective Killing of Cancer Cells by β-Lapachone: Direct Checkpoint Activation as a Strategy against Cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmed_primary_12598645

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_12598645

Other Identifiers

ISSN

0027-8424

E-ISSN

1091-6490

DOI

10.1073/pnas.0538044100

How to access this item